Synthesis and cytotoxic activity of some 2-amino-4-aryl-3-cyano-7- (dimethylamino)-4H-chromenes

Research in Pharmaceutical Sciences

Volumn 5, Issue 1, 2010, Pages 13-18

  Vosooghi, M ^a   Rajabalian, S ^b   Sorkhi, M ^a   Badinloo, M ^c   Nakhjiri, M ^d   Negahbani, A S ^d   Asadipour, A ^b   Mahdavi, M ^e   Shafiee, A ^a   Foroumadi, A ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TEHRAN   (Iran)

Author keywords

4H chromenes; Cytotoxic activity; Synthesis

Indexed keywords

2 AMINO 4 (2 BROMOPHENYL) 7 (DIMETHYLAMINO) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 4 (2 CHLOROPHENYL) 7 (DIMETHYLAMINO) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 4 (3 BROMOPHENYL) 7 (DIMETHYLAMINO) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 4 (3 CHLOROPHENYL) 7 (DIMETHYLAMINO) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 4 (4 BROMOPHENYL) 7 (DIMETHYLAMINO) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 4 (CHLOROPHENYL) 7 (DIMETHYLAMINO) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 7 (DIMETHYLAMINO) 4 (2 FLUOROPHENYL) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 7 (DIMETHYLAMINO) 4 (3 FLUOROPHENYL) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 7 (DIMETHYLAMINO) 4 (4 FLUOROPHENYL) 4H CHROMENE 3 CARBONITRILE; ALCOHOL; ALDEHYDE; ANTINEOPLASTIC AGENT; CHROMENE DERIVATIVE; PHENOL DERIVATIVE; PIPERIDINE; UNCLASSIFIED DRUG; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ASSAY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE;

EID: 78650667629     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 1994; 73: 2013-2026.
2. Kasibhatla S, Gourdeau H, Meerovitch K, Drewe J, Reddy S, Qiu L, et al. Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity. Mol Cancer Ther. 2004; 3: 1365-1374.
3. Gourdeau H, Leblond L, Hamelin B, Desputeau C, Dong K, Kianicka I, et al. Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy- phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents. Mol Cancer Ther. 2004; 3: 1375-1384.
4. Kemnitzer W, Drewe J, Jiang S, Zhang H, Wang Y, Zhao J, et al. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. J Med Chem. 2004; 47: 6299-6310.
5. Kemnitzer W, Drewe J, Jiang S, Zhang H, Zhao J, Crogan-Grundy C, et al. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7, 8-positions. J Med Chem. 2007; 50: 2858-2864.
6. Kemnitzer W, Drewe J, Jiang S, Zhang H, CroganGrundy C, Labreque D, et al. Discovery of 4-aryl4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of N-alkyl substituted pyrrole fused at the 7, 8-positions. J Med Chem. 2008; 51: 417-423.
7. Foroumadi A, Dehghan G, Samzadeh-kermani A, Arabsorkhi F, Sorkhi M, Shafiee A, et al. Synthesis and Antioxidant Activity of Some 2-Amino-4-aryl3-cyano-7-(dimethylamino)-4H-chromenes. Asian J Chem. 2007; 2: 1391-1396.
8. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65: 55-63.
9. Foroumadi A, Emami S, Rajabalian S, Badinloo M, Mohammadhosseini N, Shafiee A. N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study. Biomed Pharmacother. 2009; 63: 216-220.
10. Hashimoto M, Sagara Y, Langford D, Everall IP, Mallory M, Everson A, et al. Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3 beta pathway - implications for neuroprotection. J Biol Chem. 2002; 277: 32985-32991.